Alnylam, Moderna Agree To COVID Vax Patent Judgment
Alnylam Pharmaceuticals Inc. and Moderna Inc. on Friday agreed to a final judgment of noninfringement in Alnylam's lawsuit alleging Moderna used patented biotechnology for its Spikevax coronavirus vaccine, following a Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article